目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL NUCLEOTIDE MARKET, BY TECHNOLOGY
6.1. Overview
6.2. TaqMan Allelic Discrimination
6.3. SNP by Pyrosequencing
6.4. Gene Chips & Microarrays
6.5. Others

7. GLOBAL NUCLEOTIDE MARKET, BY APPLICATION
7.1. Overview
7.2. Food & Beverage Additive
7.3. Pharmaceuticals
7.4. Diagnostics Research
7.5. Animal Feed Additive
7.6. Others

8. GLOBAL NUCLEOTIDE MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America

9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Nucleotide Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Nucleotide Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023

10. COMPANY PROFILES
10.1. CJ CheilJedang Corp.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Star Lake Bioscience Co., Inc.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Thermo Fisher Scientific Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. MEIHUA HOLDINGS GROUP CO., LTD
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. F. Hoffmann-La Roche Ltd.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Biorigin
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. DSM Nutritional Products AG
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. PROMEGA CORPORATION
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Agilent Technologies Inc.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Lallemand Inc.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies

11. APPENDIX
11.1. References
11.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL NUCLEOTIDE MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL NUCLEOTIDE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 US: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 8 US: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 CANADA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 10 CANADA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 ITALY: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 8 ITALY: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 UK: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 UK: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 CHINA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 20 CHINA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 INDIA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 22 INDIA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: NUCLEOTIDE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: NUCLEOTIDE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NUCLEOTIDE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NUCLEOTIDE MARKET
FIGURE 4 GLOBAL NUCLEOTIDE MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 5 GLOBAL NUCLEOTIDE MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL NUCLEOTIDE MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: NUCLEOTIDE MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: NUCLEOTIDE MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: NUCLEOTIDE MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: NUCLEOTIDE MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL NUCLEOTIDE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 CJ CHEILJEDANG CORP.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 CJ CHEILJEDANG CORP.: SWOT ANALYSIS
FIGURE 14 STAR LAKE BIOSCIENCE CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 STAR LAKE BIOSCIENCE CO., INC.: SWOT ANALYSIS
FIGURE 16 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 18 MEIHUA HOLDINGS GROUP CO., LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 MEIHUA HOLDINGS GROUP CO., LTD: SWOT ANALYSIS
FIGURE 20 F. HOFFMANN-LA ROCHE LTD..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 F. HOFFMANN-LA ROCHE LTD..: SWOT ANALYSIS
FIGURE 22 BIORIGIN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BIORIGIN: SWOT ANALYSIS
FIGURE 24 DSM NUTRITIONAL PRODUCTS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 DSM NUTRITIONAL PRODUCTS AG: SWOT ANALYSIS
FIGURE 26 PROMEGA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PROMEGA CORPORATION: SWOT ANALYSIS
FIGURE 28 AGILENT TECHNOLOGIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS
FIGURE 30 LALLEMAND INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 LALLEMAND INC.: SWOT ANALYSIS